Philips is investing more than $150 million toward U.S. manufacturing and research and development with the goal of expanding the production of AI-powered health technology innovations.

While it's far from the company's first investment in its domestic operations, it aligns with the Trump administration's goals of boosting domestic manufacturing and helping the U.S. become less reliant on foreign goods.

Part of its latest investment includes the expansion of its Reedsville, Pennsylvania, manufacturing facility, which produces AI-enabled ultrasound systems for hospitals across the U.S., and the recently announced expansion of Philips’ image-guided therapy facility in Plymouth, Minnesota. The additional funds will be directed toward additional manufacturing and research and development p

See Full Page